Liraglutide inhibits the apoptosis of human nucleus pulposus cells induced by high glucose through PI3K/Akt/caspase-3 signaling pathway

Bioscience Reports
Yao Ming-YanZhou Xue

Abstract

Diabetes mellitus (DM) is a potential etiology of disc degeneration. Glucagon-like peptide-1 (GLP-1) is currently regarded as a powerful treatment option for type 2 diabetes. Apart from the beneficial effects on glycaemic control, GLP-1 has been reported to exert functions in a variety of tissues on modulation of cell proliferation, differentiation, and apoptosis. However, little is known regarding the effects of GLP-1 on nucleus pulposus cells (NPCs). In the present study, we investigated the effects of liraglutide (LIR), a long-lasting GLP-1 analogue, on apoptosis of human NPCs and the underlying mechanisms involved. We confirmed the presence of GLP-1 receptor (GLP-1R) in NPCs. Our data demonstrated that liraglutide inhibited the apoptosis of NPCs induced by high glucose (HG), as detected by Annexin V/Propidium Iodide (PI) and ELISA assays. Moreover, liraglutide down-regulated caspase-3 activity at intermediate concentration (100 nM) for maximum effect. Further analysis suggested that liraglutide suppressed reactive oxygen species (ROS) generation and stimulated the phosphorylation of Akt under HG condition. Pretreatment of cells with the Phosphoinositide 3-kinase (PI3K) inhibitor LY294002 (LY) and small interfering RNAs (siR...Continue Reading

References

Mar 9, 2000·Spine·K LuomaA Lamminen
Apr 26, 2001·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·R J MobbsK N Chandran
Dec 16, 2004·The Journal of Clinical Investigation·Masako MiuraSongtao Shi
Dec 17, 2008·Pharmacological Reviews·Wook Kim, Josephine M Egan
Jun 6, 2012·European Journal of Pharmacology·Sen ZhangXiaoguang Chen
Mar 9, 2013·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·L KarimD Vashishth
Mar 21, 2013·Apoptosis : an International Journal on Programmed Cell Death·Fan DingLi-ming Xiong
Jun 6, 2014·Annals of Medicine·Miriam MartiniEmilio Hirsch
Oct 28, 2014·Asian Spine Journal·Chae-Gwan KongEun-Young Park
Sep 20, 2015·Journal of Molecular Endocrinology·Ying YingShiwei Li
Mar 11, 2018·Journal of Cellular and Molecular Medicine·Katerina KapodistriaParaskevi Kitsiou
Mar 16, 2018·Journal of Orthopaedic Surgery and Research·Xiaoming LiuDesheng Wu
Apr 18, 2018·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Zengxin JiangJingping Wu
May 17, 2018·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Gang HouYichun Xu
Mar 9, 2019·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Zhang SenChen Xiaoguang

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
electrophoresis
Assay
PCR
transfection
ELISA

Software Mentioned

Primer Premier
ImageJ

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.